Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sravani Tekula

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Nanomedicine (London, England)|August 29, 2018
Nanoceria suppresses multiple low doses of streptozotocin-induced Type 1 diabetes by inhibition of Nrf2/NF-κB pathway and reduction of apoptosisAmit Khurana, Sravani Tekula, Chandraiah Godugu
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 19, 2018
Withaferin-A attenuates multiple low doses of Streptozotocin (MLD-STZ) induced type 1 diabetesSravani Tekula, Amit Khurana, Pratibha Anchi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 8, 2019
Therapeutic applications of selenium nanoparticlesAmit Khurana, Sravani Tekula, Mohd Aslam Saifi, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Nanomedicine (London, England)|August 29, 2018
Nanoceria suppresses multiple low doses of streptozotocin-induced Type 1 diabetes by inhibition of Nrf2/NF-κB pathway and reduction of apoptosisAmit Khurana, Sravani Tekula, Chandraiah Godugu
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 19, 2018
Withaferin-A attenuates multiple low doses of Streptozotocin (MLD-STZ) induced type 1 diabetesSravani Tekula, Amit Khurana, Pratibha Anchi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 8, 2019
Therapeutic applications of selenium nanoparticlesAmit Khurana, Sravani Tekula, Mohd Aslam Saifi, et al.
Pageof 1